Exagen Inc.
XGN
$6.88
$0.233.46%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.66M | 12.51M | 15.06M | 14.42M | 13.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.66M | 12.51M | 15.06M | 14.42M | 13.77M |
| Cost of Revenue | 5.18M | 5.53M | 6.01M | 5.82M | 5.62M |
| Gross Profit | 8.48M | 6.98M | 9.06M | 8.60M | 8.15M |
| SG&A Expenses | 10.20M | 10.16M | 10.46M | 10.54M | 12.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.04M | 17.17M | 17.65M | 17.42M | 18.91M |
| Operating Income | -3.38M | -4.66M | -2.59M | -3.00M | -5.15M |
| Income Before Tax | -3.75M | -5.03M | -2.97M | -3.36M | -5.54M |
| Income Tax Expenses | 12.00K | -- | -- | -- | 33.00K |
| Earnings from Continuing Operations | -3.76M | -5.03M | -2.97M | -3.36M | -5.57M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.76M | -5.03M | -2.97M | -3.36M | -5.57M |
| EBIT | -3.38M | -4.66M | -2.59M | -3.00M | -5.15M |
| EBITDA | -2.97M | -4.24M | -2.16M | -2.55M | -4.64M |
| EPS Basic | -0.20 | -0.28 | -0.16 | -0.19 | -0.31 |
| Normalized Basic EPS | -0.13 | -0.17 | -0.10 | -0.12 | -0.19 |
| EPS Diluted | -0.20 | -0.28 | -0.16 | -0.19 | -0.31 |
| Normalized Diluted EPS | -0.13 | -0.17 | -0.10 | -0.12 | -0.19 |
| Average Basic Shares Outstanding | 18.43M | 18.25M | 18.18M | 17.94M | 17.84M |
| Average Diluted Shares Outstanding | 18.43M | 18.25M | 18.18M | 17.94M | 17.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |